Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference newsletter


  Cervical Cancer

  Free Subscription


28.09.2020

1 Acta Oncol
1 Arch Gynecol Obstet
1 Arch Virol
1 Bioorg Med Chem Lett
1 BMC Cancer
1 BMC Public Health
1 BMJ Open
2 Brachytherapy
1 Cancer Cell Int
2 Cancer Control
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Manag Res
2 Cancer Med
1 Cancers (Basel)
1 Clin Cancer Res
1 Cytokine
1 Drug Dev Ind Pharm
1 Epigenomics
3 Eur Rev Med Pharmacol Sci
1 Gene
1 Gynecol Oncol
1 Int J Cancer
1 Int J Clin Oncol
2 Int J Environ Res Public Health
2 Int J Gynaecol Obstet
1 Int J Gynecol Cancer
1 Int J Mol Med
1 Int J Nurs Stud
1 J Cancer Educ
2 J Cell Biochem
1 J Cell Mol Med
1 J Exp Clin Cancer Res
1 J Gen Virol
1 J Immunol Res
2 J Magn Reson Imaging
1 J Natl Cancer Inst
1 JAMA Intern Med
1 Lancet Glob Health
1 Med Phys
1 Medicine (Baltimore)
1 Mol Med Rep
1 Nat Prod Res
1 Oncol Lett
1 Pan Afr Med J
1 Parasitol Res
1 PLoS One
1 Public Health
2 Radiographics
1 Radiother Oncol
1 Reprod Sci
1 Rev Assoc Med Bras (1992)
1 Rev Epidemiol Sante Publique
1 Sci Rep
1 Strahlenther Onkol
1 Urology
1 Vaccine
1 West J Emerg Med
1 Women Health
4 Zhonghua Fu Chan Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Oncol

  1. PARTANEN VM, Heinavaara S, Waldstrom M, Elfstrom KM, et al
    Adherence to international recommendations in the governance and organisation of Nordic cervical cancer screening programmes.
    Acta Oncol. 2020 Sep 21:1-8. doi: 10.1080/0284186X.2020.1821089.
    PubMed         Abstract available


    Arch Gynecol Obstet

  2. BENOIT L, Koual M, Nguyen-Xuan HT, Balaya V, et al
    Does a pre-operative conization improve disease-free survival in early-stage cervical cancer?
    Arch Gynecol Obstet. 2020 Sep 22. pii: 10.1007/s00404-020-05798.
    PubMed         Abstract available


    Arch Virol

  3. WANG J, Liu J, Song G, Cao Z, et al
    Internally controlled recombinase-aided amplification (IC-RAA) assays for the detection of human papillomavirus genotypes 16 and 18 using extracted DNA and samples treated with nucleic acid releasing agent.
    Arch Virol. 2020;165:2241-2247.
    PubMed         Abstract available


    Bioorg Med Chem Lett

  4. ZHU XL, Tian XQ, Xu HH, Wang HM, et al
    Rhopaladins' analogue (E)-2-aroyl-4-(4-fluorobenzylidene)-5-oxopyrrolidines inhibit proliferation, promote apoptosis and down-regulation of E6/E7 mRNA in cervical cancer.
    Bioorg Med Chem Lett. 2020;30:127554.
    PubMed         Abstract available


    BMC Cancer

  5. YAO T, Weng X, Yao Y, Huang C, et al
    ALDH-1-positive cells exhibited a radioresistant phenotype that was enhanced with hypoxia in cervical cancer.
    BMC Cancer. 2020;20:891.
    PubMed         Abstract available


    BMC Public Health

  6. STEPHENS S, Chatterjee A, Coles V, Crawford R, et al
    The costs of treating vaginal and vulval cancer in England (2009-2015).
    BMC Public Health. 2020;20:453.
    PubMed         Abstract available


    BMJ Open

  7. MCHOME B, Swai P, Wu C, Katanga J, et al
    Comprehensive Cervical Cancer Prevention in Tanzania (CONCEPT) study: Cohort profile.
    BMJ Open. 2020;10:e038531.
    PubMed         Abstract available


    Brachytherapy

  8. DEUFEL CL, Tian S, Yan BB, Vaishnav BD, et al
    Automated applicator digitization for high-dose-rate cervix brachytherapy using image thresholding and density-based clustering.
    Brachytherapy. 2020;19:111-118.
    PubMed         Abstract available

  9. KELLER A, Rodriguez-Lopez JL, Patel AK, Vargo JA, et al
    Early outcomes after definitive chemoradiation therapy with Vienna/Venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: A single-institution experience.
    Brachytherapy. 2020 Sep 17. pii: S1538-4721(20)30181.
    PubMed         Abstract available


    Cancer Cell Int

  10. CHEN X, Yang J, Wang Y
    LncRNA JPX promotes cervical cancer progression by modulating miR-25-3p/SOX4 axis.
    Cancer Cell Int. 2020;20:441.
    PubMed         Abstract available


    Cancer Control

  11. GEMEDA EY, Kare BB, Negera DG, Bona LG, et al
    Prevalence and Predictor of Cervical Cancer Screening Service Uptake Among Women Aged 25 Years and Above in Sidama Zone, Southern Ethiopia, Using Health Belief Model.
    Cancer Control. 2020;27:1073274820954460.
    PubMed         Abstract available

  12. SHOKAR NK, Doan A, Calderon-Mora J, Lakshmanaswamy R, et al
    The Prevalence of Genital Human Papillomavirus Subtypes in a Cohort of Hispanic Women Presenting for Cervical Cancer Screening Along the US-Mexico Border.
    Cancer Control. 2020;27:1073274820951780.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  13. ROHNER E, Edelman C, Sanusi B, Schmitt JW, et al
    Extended HPV genotyping to compare HPV type-distribution in self and provider-collected samples for cervical cancer screening.
    Cancer Epidemiol Biomarkers Prev. 2020 Sep 17. pii: 1055-9965.EPI-20-0674.
    PubMed         Abstract available


    Cancer Manag Res

  14. WANG J, Zhu X, Ying P, Zhu Y, et al
    PIF1 Affects the Proliferation and Apoptosis of Cervical Cancer Cells by Influencing TERT.
    Cancer Manag Res. 2020;12:7827-7835.
    PubMed         Abstract available


    Cancer Med

  15. NAKALEMBE M, Makanga P, Kambugu A, Laker-Oketta M, et al
    A public health approach to cervical cancer screening in Africa through community-based self-administered HPV testing and mobile treatment provision.
    Cancer Med. 2020 Sep 23. doi: 10.1002/cam4.3468.
    PubMed         Abstract available

  16. GENNIGENS C, De Cuypere M, Seidel L, Hermesse J, et al
    Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy.
    Cancer Med. 2020 Sep 20. doi: 10.1002/cam4.3465.
    PubMed         Abstract available


    Cancers (Basel)

  17. GADDUCCI A, Cosio S
    Pharmacological Treatment of Patients with Metastatic, Recurrent or Persistent Cervical Cancer Not Amenable by Surgery or Radiotherapy: State of Art and Perspectives of Clinical Research.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available


    Clin Cancer Res

  18. TINKER AV, Hirte HW, Provencher DM, Butler MO, et al
    Dose-ranging and cohort-expansion study of monalizumab(IPH2201) in advanced gynecologic malignancies:A trial of the Canadian Cancer Trials Group (CCTG):IND221.
    Clin Cancer Res. 2019 Jul 15. pii: 1078-0432.CCR-19-0298.
    PubMed         Abstract available


    Cytokine

  19. SHI WJ, Liu H, Ge YF, Wu D, et al
    LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway.
    Cytokine. 2020;136:155286.
    PubMed         Abstract available


    Drug Dev Ind Pharm

  20. HONG D, Zhao HM
    Eu(III)-coordination polymer: inhibitory activity on cervical cancer via inducing ROS mediated apoptosis.
    Drug Dev Ind Pharm. 2020 Sep 22:1-14. doi: 10.1080/03639045.2020.1826508.
    PubMed         Abstract available


    Epigenomics

  21. NAHAND JS, Vandchali NR, Darabi H, Doroudian M, et al
    Exosomal microRNAs: novel players in cervical cancer.
    Epigenomics. 2020 Sep 22. doi: 10.2217/epi-2020-0026.
    PubMed         Abstract available


    Eur Rev Med Pharmacol Sci

  22. WANG AH, Zhao JM, Du J, Pang QX, et al
    Long noncoding RNA LUCAT1 promotes cervical cancer cell proliferation and invasion by upregulating MTA1.
    Eur Rev Med Pharmacol Sci. 2020;24:8623.
    PubMed         Abstract available

  23. LI Y, Huang Y, Zhou C, Jiang PC, et al
    MiR-320c prevents the malignant development of cervical cancer by regulating GABRP level.
    Eur Rev Med Pharmacol Sci. 2020;24:8731-8739.
    PubMed         Abstract available

  24. ZHANG YN, Liu B, Jiang T, Li Q, et al
    Long non-coding RNA CASC15 promotes proliferation and induces apoptosis of cervical cancer cells through targeting miR-101-3p.
    Eur Rev Med Pharmacol Sci. 2020;24:8627.
    PubMed         Abstract available


    Gene

  25. YANG L, Yang Y, Meng M, Wang W, et al
    Identification of prognosis-related genes in the cervical cancer immune microenvironment.
    Gene. 2020;766:145119.
    PubMed         Abstract available


    Gynecol Oncol

  26. YOSHIMOTO Y, Sasaki Y, Murata K, Noda SE, et al
    Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
    Gynecol Oncol. 2020 Sep 17. pii: S0090-8258(20)33821.
    PubMed         Abstract available


    Int J Cancer

  27. VENETIANER R, Clarke MA, van der Marel J, Tota J, et al
    Identification of HPV Genotypes Causing Cervical Pre-Cancer using Tissue-Based Genotyping.
    Int J Cancer. 2020 Feb 9. doi: 10.1002/ijc.32919.
    PubMed         Abstract available


    Int J Clin Oncol

  28. NAGAO S, Yamamoto K, Oishi T, Yamaguchi S, et al
    Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer.
    Int J Clin Oncol. 2020 Sep 22. pii: 10.1007/s10147-020-01787.
    PubMed         Abstract available


    Int J Environ Res Public Health

  29. RIZA E, Karakosta A, Tsiampalis T, Lazarou D, et al
    Knowledge, Attitudes and Perceptions about Cervical Cancer Risk, Prevention and Human Papilloma Virus (HPV) in Vulnerable Women in Greece.
    Int J Environ Res Public Health. 2020;17.
    PubMed         Abstract available

  30. LORINI C, Caini S, Ierardi F, Bachini L, et al
    Health Literacy as a Shared Capacity: Does the Health Literacy of a Country Influence the Health Disparities among Immigrants?
    Int J Environ Res Public Health. 2020;17.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  31. PATABENDIGE M, Wijesinghe RD, Wijesuriya MWAB, Hapuachchige C, et al
    Surgical management of cervical cancer in a resource-limited setting: One year of data from the National Cancer Institute, Sri Lanka.
    Int J Gynaecol Obstet. 2020 Sep 22. doi: 10.1002/ijgo.13384.
    PubMed         Abstract available

  32. MICHAAN N, Laskov I, Aizic A, Brautbar O, et al
    Laparoscopic sentinel lymph node dissection followed by open radical hysterectomy for early stage cervical cancer: A pilot study.
    Int J Gynaecol Obstet. 2020 Sep 22. doi: 10.1002/ijgo.13383.
    PubMed         Abstract available


    Int J Gynecol Cancer

  33. SALVO G, Odetto D, Saenz Perrotta C, Noll F, et al
    Tumor size in cervical cancer: an ongoing dilemma.
    Int J Gynecol Cancer. 2020 Sep 21. pii: ijgc-2020-002022.
    PubMed        


    Int J Mol Med

  34. CHEN X, Cao R, Liu H, Zhang T, et al
    MicroRNA15a5ptargeting oncogene YAP1 inhibits cell viability and induces cell apoptosis in cervical cancer cells.
    Int J Mol Med. 2020 Aug 12. doi: 10.3892/ijmm.2020.4704.
    PubMed         Abstract available


    Int J Nurs Stud

  35. SHI Y, Cai J, Wu Z, Jiang L, et al
    Effects of a nurse-led positive psychology intervention on sexual function, depression and subjective well-being in postoperative patients with early-stage cervical cancer: A randomized controlled trial.
    Int J Nurs Stud. 2020;111:103768.
    PubMed         Abstract available


    J Cancer Educ

  36. DALLA V, Panagiotopoulou EK, Deltsidou A, Kalogeropoulou M, et al
    Level of Awareness Regarding Cervical Cancer Among Female Syrian Refugees in Greece.
    J Cancer Educ. 2020 Sep 22. pii: 10.1007/s13187-020-01873.
    PubMed         Abstract available


    J Cell Biochem

  37. MA WG, Shi SM, Chen L, Lou G, et al
    SP1-induced lncRNA FOXD3-AS1 contributes to tumorigenesis of cervical cancer by modulating the miR-296-5p/HMGA1 pathway.
    J Cell Biochem. 2020 Sep 22. doi: 10.1002/jcb.29846.
    PubMed         Abstract available

  38. LUAN Y, Xie B, Wei W
    REST-repressed lncRNA NPPA-AS1 regulates cervical cancer progression by modulating miR-302e/DKK1/Wnt/beta-catenin signaling pathway.
    J Cell Biochem. 2020 Sep 23. doi: 10.1002/jcb.29701.
    PubMed         Abstract available


    J Cell Mol Med

  39. YANG WT, Feng Q, Ma HM, Lei D, et al
    NF-YA promotes the cell proliferation and tumorigenic properties by transcriptional activation of SOX2 in cervical cancer.
    J Cell Mol Med. 2020 Sep 20. doi: 10.1111/jcmm.15777.
    PubMed         Abstract available


    J Exp Clin Cancer Res

  40. YANG Y, Wang Q, Song D, Zen R, et al
    Lysosomal dysfunction and autophagy blockade contribute to autophagy-related cancer suppressing peptide-induced cytotoxic death of cervical cancer cells through the AMPK/mTOR pathway.
    J Exp Clin Cancer Res. 2020;39:197.
    PubMed         Abstract available


    J Gen Virol

  41. ARROYO MUHR LS, Lagheden C, Eklund C, Lei J, et al
    Sequencing detects human papillomavirus in some apparently HPV-negative invasive cervical cancers.
    J Gen Virol. 2019 Dec 20. doi: 10.1099/jgv.0.001374.
    PubMed         Abstract available


    J Immunol Res

  42. YIN H, Guo W, Sun X, Li R, et al
    TILs and Anti-PD1 Therapy: An Alternative Combination Therapy for PDL1 Negative Metastatic Cervical Cancer.
    J Immunol Res. 2020;2020:8345235.
    PubMed         Abstract available


    J Magn Reson Imaging

  43. LI B, Sun H, Zhang S, Wang X, et al
    Amide proton transfer imaging to evaluate the grading of squamous cell carcinoma of the cervix: A comparative study using (18) F FDG PET.
    J Magn Reson Imaging. 2018 Nov 14. doi: 10.1002/jmri.26572.
    PubMed         Abstract available

  44. BALAJI R
    Editorial for: "PET/MRI in Cervical Cancer: Associations Between Imaging Biomarkers and Tumor Stage, Disease Progression, and Overall Survival".
    J Magn Reson Imaging. 2020 Sep 23. doi: 10.1002/jmri.27380.
    PubMed        


    J Natl Cancer Inst

  45. BARLOW WE, Beaber EF, Geller BM, Kamineni A, et al
    Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium.
    J Natl Cancer Inst. 2019 Jul 11. pii: 5530599. doi: 10.1093.
    PubMed         Abstract available


    JAMA Intern Med

  46. QIN J, Saraiya M, Martinez G, Sawaya GF, et al
    Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States.
    JAMA Intern Med. 2020;180:274-280.
    PubMed         Abstract available


    Lancet Glob Health

  47. ZOU Z, Fairley CK, Ong JJ, Hocking J, et al
    Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis.
    Lancet Glob Health. 2020;8:e1335-e1344.
    PubMed         Abstract available


    Med Phys

  48. RHEE DJ, Jhingran A, Rigaud B, Netherton T, et al
    Automatic contouring system for cervical cancer using convolutional neural networks.
    Med Phys. 2020 Sep 22. doi: 10.1002/mp.14467.
    PubMed         Abstract available


    Medicine (Baltimore)

  49. CHAU JPC, Lo SHS, Choi KC, Lee VWY, et al
    Effects of a multidisciplinary team-led school-based human papillomavirus vaccination health-promotion programme on improving vaccine acceptance and uptake among female adolescents: A cluster randomized controlled trial.
    Medicine (Baltimore). 2020;99:e22072.
    PubMed         Abstract available


    Mol Med Rep

  50. WANG M, Wang X, Liu W
    MicroRNA130a3p promotes the proliferation and inhibits the apoptosis of cervical cancer cells via negative regulation of RUNX3.
    Mol Med Rep. 2020 Jul 28. doi: 10.3892/mmr.2020.11368.
    PubMed         Abstract available


    Nat Prod Res

  51. TANG Z, Lu L, Zhou X, Shen J, et al
    A new cytotoxic polycyclic polyprenylated acylphloroglucinol from Garcinia nujiangensis screened by the LC-PDA and LC-MS.
    Nat Prod Res. 2020;34:2448-2455.
    PubMed         Abstract available


    Oncol Lett

  52. OBOSHI W, Hayashi K, Takeuchi H, Ikeda K, et al
    MicroRNA-150 suppresses p27(Kip1) expression and promotes cell proliferation in HeLa human cervical cancer cells.
    Oncol Lett. 2020;20:210.
    PubMed         Abstract available


    Pan Afr Med J

  53. NWANKWO TO, Umeh UA, Aniebue UU, Onu JU, et al
    Impact of neoadjuvant chemotherapy in improving operative intervention in the management of cervical cancer in low resource setting: a preliminary report.
    Pan Afr Med J. 2020;36:210.
    PubMed         Abstract available


    Parasitol Res

  54. SU RY, Ho LJ, Yang HY, Chung CH, et al
    Association between Trichomonas vaginalis infection and cervical lesions: a population-based, nested case-control study in Taiwan.
    Parasitol Res. 2020;119:2649-2657.
    PubMed         Abstract available


    PLoS One

  55. ENDALEW DA, Moti D, Mohammed N, Redi S, et al
    Knowledge and practice of cervical cancer screening and associated factors among reproductive age group women in districts of Gurage zone, Southern Ethiopia. A cross-sectional study.
    PLoS One. 2020;15:e0238869.
    PubMed         Abstract available


    Public Health

  56. BENAVIDEZ G, Asare M, Lanning B, Ylitalo K, et al
    Young adults' human papillomavirus-related knowledge: source of medical information matters.
    Public Health. 2020;182:125-130.
    PubMed         Abstract available


    Radiographics

  57. JAVITT MC
    Invited Commentary: FIGO Staging Classification for Cervical Cancer-Behold the Big Picture.
    Radiographics. 2020 Sep 18:200153. doi: 10.1148/rg.2020200153.
    PubMed        

  58. SALIB MY, Russell JHB, Stewart VR, Sudderuddin SA, et al
    2018 FIGO Staging Classification for Cervical Cancer: Added Benefits of Imaging.
    Radiographics. 2020 Sep 18:200013. doi: 10.1148/rg.2020200013.
    PubMed         Abstract available


    Radiother Oncol

  59. GORT EM, Beukema JC, Matysiak W, Sijtsema NM, et al
    Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer.
    Radiother Oncol. 2020 Sep 18. pii: S0167-8140(20)30797.
    PubMed         Abstract available


    Reprod Sci

  60. ZHANG J
    Targeting mTOR by CZ415 Suppresses Cell Proliferation and Promotes Apoptosis via Lipin-1 in Cervical Cancer In Vitro and In Vivo.
    Reprod Sci. 2020 Sep 17. pii: 10.1007/s43032-020-00313.
    PubMed         Abstract available


    Rev Assoc Med Bras (1992)

  61. OLIVEIRA MSF, Sorpreso ICE, Zuchelo LTS, Silva ATMD, et al
    Knowledge and acceptability of HPV vaccine among HPV-vaccinated and unvaccinated adolescents at Western Amazon.
    Rev Assoc Med Bras (1992). 2020;66:1062-1069.
    PubMed         Abstract available


    Rev Epidemiol Sante Publique

  62. BRUEL S, Peyrard-Chevrier K, Ginzarly M, Frappe P, et al
    Human papillomavirus (HPV) vaccination: What can be found on the Web? Qualitative analysis of the Doctissimo.fr forum data.
    Rev Epidemiol Sante Publique. 2020;68:25-31.
    PubMed         Abstract available


    Sci Rep

  63. LARSEN PT, Jorgensen SF, Tranberg M, Njor SH, et al
    Screening participation after a false positive result in organized cervical cancer screening: a nationwide register-based cohort study.
    Sci Rep. 2020;10:15427.
    PubMed         Abstract available


    Strahlenther Onkol

  64. MORGENTHALER J, Kohler C, Budach V, Sehouli J, et al
    Long-term results of robotic radiosurgery for non brachytherapy patients with cervical cancer.
    Strahlenther Onkol. 2020 Sep 24. pii: 10.1007/s00066-020-01685.
    PubMed         Abstract available


    Urology

  65. BELLER HL, Rapp DE, Zillioux J, Abdalla B, et al
    Urologic complications requiring intervention following high-dose pelvic radiation for cervical cancer.
    Urology. 2020 Sep 19. pii: S0090-4295(20)31153.
    PubMed         Abstract available


    Vaccine

  66. RUSS SM, Brackney M, Meek J, Niccolai LM, et al
    Missed Opportunities for HPV Vaccination Among Vaccine-Eligible Women with High Grade Cervical Lesions.
    Vaccine. 2019 Jun 24. pii: S0264-410X(19)30836.
    PubMed         Abstract available


    West J Emerg Med

  67. WALTER LA, Leader E, Galbraith JW
    Human Papillomavirus Awareness, Vaccine Status, and Risk Factors in Female Emergency Patients.
    West J Emerg Med. 2020;21:203-208.
    PubMed         Abstract available


    Women Health

  68. FARAHMAND Z, Soleimanjahi H, Garshasbi M, Hasanzadeh M, et al
    Distribution of the most common types of HPV in Iranian women with and without cervical cancer.
    Women Health. 2020 Sep 21:1-10. doi: 10.1080/03630242.2020.1822490.
    PubMed         Abstract available


    Zhonghua Fu Chan Ke Za Zhi

  69. CHEN CL, Kang S, Chen BL, Yang Y, et al
    [Long-term oncological outcomes of laparoscopic versus abdominal surgery in stage a1 LVSI(+)-b1 cervical cancer patients with different tumor size: a big database in China].
    Zhonghua Fu Chan Ke Za Zhi. 2020;55:589-599.
    PubMed         Abstract available

  70. ZHANG YN, Li B, Wang YT, Liu SH, et al
    [Efficacy and safety of laparoscopic radical hysterectomy for early cervical adenocarcinoma].
    Zhonghua Fu Chan Ke Za Zhi. 2020;55:600-608.
    PubMed         Abstract available

  71. LING KJ, Wang YZ, Zhang H, Zhang XY, et al
    [Oncologic outcomes of early stage cervical cancer performed operation by different laparoscopic surgical procedures: analysis of clinical data from mutiple centers].
    Zhonghua Fu Chan Ke Za Zhi. 2020;55:617-623.
    PubMed         Abstract available

  72. XU YP, Wang ZQ, Liang XD, Wang Y, et al
    [Comparative analysis of the prognosis of patients with locally advanced cervical cancer undergoing laparoscopic or abdominal surgery].
    Zhonghua Fu Chan Ke Za Zhi. 2020;55:609-616.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: